Sabra Healthcare REIT is a reit-healthcare facilities business based in the US. Sabra Healthcare REIT shares (SBRA) are listed on the NASDAQ and all prices are listed in US Dollars. Sabra Healthcare REIT employs 42 staff and has a trailing 12-month revenue of around $419.2 million.
Finder Award
SoFi Invest
tastyworks
| Latest market close | $13.46 |
|---|---|
| 52-week range | $10.71 - $15.91 |
| 50-day moving average | $12.72 |
| 200-day moving average | $13.58 |
| Wall St. target price | $14.08 |
| PE ratio | 69.2105 |
| Dividend yield | $1.2 (9.06%) |
| Earnings per share (TTM) | $0.19 |
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $13.46 from 2023-01-27
| 1 week (2023-01-18) | N/A |
|---|---|
| 1 month (2022-12-28) | 9.61% |
| 3 months (2022-10-27) | 0.37% |
| 6 months (2022-07-29) | -12.54% |
| 1 year (2022-01-28) | 0.90% |
|---|---|
| 2 years (2021-01-29) | -19.83% |
| 3 years (2020-01-29) | 22.31 |
| 5 years (2018-01-29) | 18.01 |
Valuing Sabra Healthcare REIT stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sabra Healthcare REIT's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Sabra Healthcare REIT's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 69x. In other words, Sabra Healthcare REIT shares trade at around 69x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Sabra Healthcare REIT's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.15. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Sabra Healthcare REIT's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Sabra Healthcare REIT's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $241 million.
The EBITDA is a measure of a Sabra Healthcare REIT's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $419.2 million |
|---|---|
| Operating margin TTM | 10.63% |
| Gross profit TTM | $246.6 million |
| Return on assets TTM | 0.46% |
| Return on equity TTM | -0.52% |
| Profit margin | -4.06% |
| Book value | $13.89 |
| Market capitalisation | $3 billion |
TTM: trailing 12 months
We're not expecting Sabra Healthcare REIT to pay a dividend over the next 12 months.
Sabra Healthcare REIT's shares were split on a 1:3 basis on 15 November 2010. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sabra Healthcare REIT shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Sabra Healthcare REIT shares which in turn could have impacted Sabra Healthcare REIT's share price.
Over the last 12 months, Sabra Healthcare REIT's shares have ranged in value from as little as $10.7055 up to $15.9053. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sabra Healthcare REIT's is 1.2804. This would suggest that Sabra Healthcare REIT's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities ("Senior Housing - Leased"), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements ("Senior Housing - Managed"), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada. .
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
